Senomyx, Inc. (NASDAQ:SNMX) has received an average broker rating score of 3.00 (Hold) from the four analysts that cover the company, Zacks Investment Research reports. Four analysts have rated the stock with a hold rating. Senomyx’s rating score has declined by 33.3% from 90 days ago as a result of various analysts’ ratings changes.

Brokerages have set a one year consensus target price of $3.25 for the company and are forecasting that the company will post ($0.10) EPS for the current quarter, according to Zacks. Zacks has also given Senomyx an industry rank of 171 out of 265 based on the ratings given to related companies.

Several equities research analysts have recently weighed in on the stock. Needham & Company LLC downgraded shares of Senomyx from a “buy” rating to a “hold” rating in a research report on Friday, October 28th. Roth Capital set a $2.00 target price on shares of Senomyx and gave the stock a “hold” rating in a research report on Sunday, October 30th. Finally, Craig Hallum downgraded shares of Senomyx from a “buy” rating to a “hold” rating and set a $2.00 target price for the company. in a research report on Friday, October 28th.

Senomyx (NASDAQ:SNMX) traded up 1.67% on Friday, reaching $1.22. 387,514 shares of the company traded hands. The company has a 50-day moving average price of $0.97 and a 200-day moving average price of $2.62. The company’s market capitalization is $54.90 million. Senomyx has a 12 month low of $0.78 and a 12 month high of $4.85.

Senomyx (NASDAQ:SNMX) last released its earnings results on Thursday, October 27th. The company reported ($0.05) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.07) by $0.02. The company earned $6 million during the quarter, compared to the consensus estimate of $5.36 million. Senomyx had a negative net margin of 39.68% and a negative return on equity of 54.22%. The company’s revenue was down 18.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.05) EPS. Equities research analysts expect that Senomyx will post ($0.25) EPS for the current year.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. TD Asset Management Inc. raised its position in Senomyx by 22.7% in the third quarter. TD Asset Management Inc. now owns 24,300 shares of the company’s stock valued at $104,000 after buying an additional 4,500 shares during the period. Morgan Stanley raised its position in Senomyx by 73.2% in the third quarter. Morgan Stanley now owns 44,154 shares of the company’s stock valued at $189,000 after buying an additional 18,661 shares during the period. KCG Holdings Inc. raised its position in Senomyx by 206.2% in the second quarter. KCG Holdings Inc. now owns 44,816 shares of the company’s stock valued at $123,000 after buying an additional 30,180 shares during the period. Monarch Partners Asset Management LLC acquired a new position in Senomyx during the third quarter valued at approximately $211,000. Finally, Alpine Partners VI LLC acquired a new position in Senomyx during the second quarter valued at approximately $165,000. 49.68% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this article on another site, it was illegally stolen and republished in violation of United States & international copyright laws. The original version of this article can be viewed at http://www.dailypolitical.com/2017/01/13/zacks-senomyx-inc-snmx-given-3-25-consensus-target-price-by-brokerages.html.

Senomyx Company Profile

Senomyx, Inc is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries. The Company operates through development and commercialization of flavor ingredients segment. It is engaged in the discovery, development and/or commercialization of flavor ingredients through over five programs.

5 Day Chart for NASDAQ:SNMX

Get a free copy of the Zacks research report on Senomyx (SNMX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Senomyx Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senomyx Inc. and related companies with MarketBeat.com's FREE daily email newsletter.